Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 5/3074% above fair value
$6.12+0.82 (+15.47%)
Close on Nov 11, 2026Market cap $91.70MP/E –Yield –
Cumberland Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cumberland Pharmaceuticals's ebitda for the twelve months ending Jun 30, 2026 was -$5.49M. For fiscal 2025 it was $1.35M. Over ten years it grew -8.7% a year on average. The highest annual figure on record is $10.89M in fiscal 2011.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.35M | – |
| FY2024 | Dec 31, 2024 | -$1.53M | – |
| FY2023 | Dec 31, 2023 | -$4.62M | – |
| FY2022 | Dec 31, 2022 | -$376.82K | – |
| FY2021 | Dec 31, 2021 | -$3.07M | – |
| FY2020 | Dec 31, 2020 | -$1.63M | – |
| FY2019 | Dec 31, 2019 | -$4.88M | – |
| FY2018 | Dec 31, 2018 | -$8.19M | – |
| FY2017 | Dec 31, 2017 | -$1.43M | -248.7% |
| FY2016 | Dec 31, 2016 | $963.78K | -71.3% |
| FY2015 | Dec 31, 2015 | $3.36M | -39.5% |
| FY2014 | Dec 31, 2014 | $5.55M | – |
| FY2013 | Dec 31, 2013 | -$2.50M | -125.7% |
| FY2012 | Dec 31, 2012 | $9.72M | -10.7% |
| FY2011 | Dec 31, 2011 | $10.89M | +45.6% |
| FY2010 | Dec 31, 2010 | $7.48M | +13.5% |
| FY2009 | Dec 31, 2009 | $6.59M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.37M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.85M | -179.7% |
| Q4 FY2025 | Dec 31, 2025 | -$329.31K | – |
| Q3 FY2025 | Sep 30, 2025 | $1.06M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.07M | -3712.5% |
| Q1 FY2025 | Mar 31, 2025 | $2.32M | – |
| Q4 FY2024 | Dec 31, 2024 | -$345.65K | – |
| Q3 FY2024 | Sep 30, 2024 | -$578.40K | – |
| Q2 FY2024 | Jun 30, 2024 | $112.76K | -90.8% |
| Q1 FY2024 | Mar 31, 2024 | -$718.57K | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.95M | – |
| Q3 FY2023 | Sep 30, 2023 | -$620.51K | -149.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.22M | – |
| Q1 FY2023 | Mar 31, 2023 | -$276.00K | -176.3% |
| Q4 FY2022 | Dec 31, 2022 | -$1.77M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.26M | – |
| Q2 FY2022 | Jun 30, 2022 | -$228.20K | – |
| Q1 FY2022 | Mar 31, 2022 | $361.75K | -60.0% |
| Q4 FY2021 | Dec 31, 2021 | -$3.28M | – |
| Q3 FY2021 | Sep 30, 2021 | -$489.73K | – |
| Q2 FY2021 | Jun 30, 2021 | -$207.76K | – |
| Q1 FY2021 | Mar 31, 2021 | $903.31K | – |
| Q4 FY2020 | Dec 31, 2020 | -$522.07K | – |
| Q3 FY2020 | Sep 30, 2020 | -$18.67K | – |
| Q2 FY2020 | Jun 30, 2020 | -$398.36K | – |
| Q1 FY2020 | Mar 31, 2020 | -$693.94K | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.27M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.09M | – |
| Q2 FY2019 | Jun 30, 2019 | -$275.27K | – |
| Q1 FY2019 | Mar 31, 2019 | -$247.69K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.39M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.09M | – |
| Q2 FY2018 | Jun 30, 2018 | -$167.24K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.76M | -47866.3% |
| Q4 FY2017 | Dec 31, 2017 | -$229.77K | – |
| Q3 FY2017 | Sep 30, 2017 | -$179.45K | -124.1% |
| Q2 FY2017 | Jun 30, 2017 | -$1.03M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.68K | – |
| Q4 FY2016 | Dec 31, 2016 | -$345.52K | – |
| Q3 FY2016 | Sep 30, 2016 | $743.75K | – |
See a number that looks wrong?